Cough Syrup
New Delhi; News Agency: Selling potentially life-threatening drugs is an invitation to a major disaster. In India too, the Central Drug Standard Control Organization (CDSCO) launched an inspection drive between August 2023 and February 2024 following drug-related deaths in various African countries, including The Gambia. His findings have come out and after testing 10 medicines, the chemicals Di-Ethylene Glycol (DEG) and Ethylene Glycol (EG) have been found in lethal quantities.
Of the 10 drugs examined, six are given to children for coughs. Especially due to this one reason, these findings of CDSCO have become shocking and due to this, there has been a stir in the country.
Over 140 children have died from cough syrup in the past one to two years in various African countries including Gambia, Cameroon and Uzbekistan. These deaths were attributed to the presence of chemicals in the syrup. All these cough syrups were manufactured in India. Against this background, from June 2023 CDSCO has made laboratory testing of all cough syrups to be exported mandatory. Under this, samples of 54 pharma companies have failed between June and October 23.
These 6 cough medicines fail
Two batches of Kofvon LS, Guaifenesin Syrup-100, Guaifenesin, Silpro Plus, Cold Out.
Amount of hazardous chemicals
Cough syrup Trimax expectorant contains 0.118 percent EG. Cold Out had 1.9 EG and 0.14 percent DEG. EG and DEG were found in large amounts in Diziver injection for heart disease. 0.171 percent EG and 0.243 percent DEG were found in the allergy medicine Silpro Plus Syrup. According to the guidelines of the World Health Organization, the amount of EG or DEG should not exceed 0.10 percent.
